|Start:||Mar 20, 2019 - 8:00 am|
|End:||Mar 20, 2019 - 10:00 am|
|Venue:||European Parliament - Brussels|
On behalf of the European Alliance for Access to Safe Medicines (EAASM), an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines, we are delighted to invite you to a Breakfast Session on:
Nanomedicines are an emerging product class in the health sector which has been gaining increasing attention in academia and research over the past twenty years. It has the potential to provide personalised, yet more affordable, healthcare while at the same time offering better quality of life for the sick and injured, opening up numerous potential pathways to improving medical diagnosis and therapy. However there is a need to establish robust regulation that is fit for purpose, such as the creation of harmonised definitions across Europe and development of protocols for their characterization, evaluation and pharmacovigilance oversight once an NCE is marketed.
This meeting aims to discuss the appropriateness of the current regulatory approval process for nanomedicines and their follow-on products, with an analysis of the potential implications for policymakers, regulators, payers, physicians and patients. We would like to encourage a meaningful political participation and policy actionsuggestions which would be designed to boost research and innovation. In addition proposals to develop andamend the existing regulatory framework and to enhance priority areas for the development and evaluation of nanomedicines.
The breakfast meeting will be kindly hosted by MEP José Inácio FARIA (EPP, Portugal) and will take place on Wednesday 20 March 2019, from 8:00 to 10:00, in the Members Salon of the European Parliament (Brussels).
- Please save this date or confirm your attendance here;
- If you would like further information, please do not hesitate to contact Laura Cigolot firstname.lastname@example.org
The European Alliance for Access to Safe Medicines (EAASM) is an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines. The Alliance was formed by a cross-section of European stake-holders from a variety of backgrounds. Its key activities include campaigning for the safer use of unlicensed or off-label medicines and also the exclusion of counterfeit and substandard medicines from the supply chain, raising public awareness around such issues, and promoting effective legislation and enforcement in relation to falsified medicines. For a leaflet summarising the EAASM’s activities and achievements click here
The European Alliance for Access to Safe Medicines
1386 London Road, Leigh-on-Sea, Essex SS9 2UJ